The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
Background: To identify the role of combination biopsy, which consists of both targeted and additional systematic cores, in the diagnosis of clinically significant prostate cancer (csPCa). Methods: We retrospectively reviewed patients with PSA levels 2.5–15 ng/mL who have a suspicious prostate lesio...
Guardado en:
Autores principales: | Chung Un Lee, Joongwon Choi, Si Hyun Sung, Jae Hoon Chung, Wan Song, Minyong Kang, Hyun Hwan Sung, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Hwang Gyun Jeon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/51d559f2a3254cb7bf2d791e4150cd9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy
por: Pawel Rajwa, et al.
Publicado: (2021) -
Recent Advances in Systematic and Targeted Prostate Biopsies
por: Devetzis K, et al.
Publicado: (2021) -
Transperineal prostate biopsy identifies locations of clinically significant prostate cancer in men considering focal therapy with PI‐RADS 3–5 regions of interest
por: Nelson Stone, et al.
Publicado: (2021) -
Concordancia diagnóstica del puntaje de Gleason en biopsia por punción y prostatectomía radical y sus consecuencias clínicas
por: Arellano H,Leonardo, et al.
Publicado: (2004) -
How to Improve TRUS-Guided Target Biopsy following Prostate MRI
por: Byung Kwan Park
Publicado: (2021)